From participant recruitment and retention to ensuring diversity and minimising patient burden, the world of clinical trials faces a unique set of challenges.
Decentralised clinical trials (DCTs) have emerged as a potential solution, promising to address some of these longstanding issues. But are they truly the solution we’ve been waiting for, or do they bring new challenges of their own?
At a recent webinar, Branding Science Director, Chris Recaldin, explored the true impact of decentralising clinical trials.
Click here to take a look at our full article and dive into their key insights.
Want an even more in-depth look? Click here to watch the webinar in full on demand.
Get in touch:
Chris Recaldin, Director: [email protected]